WATERTOWN, Mass.--(BUSINESS WIRE)--FORMA Therapeutics today announced the appointment of Paolo Paoletti, M.D., former President, GlaxoSmithKline (GSK) Oncology, to the company’s Board of Directors. In addition to serving as a director, Dr. Paoletti will also lead FORMA’s Research & Development Committee as its chairperson; in this capacity, his strategic clinical and research insights will be applied to FORMA’s target family drug discovery paradigm.
Help employers find you! Check out all the jobs and post your resume.
